ASX Small and Mid-Cap Conference

Ansarada Group (ASX: AND) is a global provider of cloud-based SaaS information governance solutions which enable businesses and advisors to achieve critical outcomes with confidence, through secure document management, workflow and collaboration tools. Ansarada Group has four market-leading solutions that increase productivity, efficiencies and facilitate better decision-making. They are scalable, serverless and leverage artificial intelligence and machine learning. For more information please visit www.ansarada.com/blog

Speaker: Sam Riley, Chief Executive Officer

Austin Engineering (ASX: ANG) is a market leader in the design, engineering and manufacture of loading and hauling solutions, including off-highway dump truck bodies, buckets, and water tanks for multi-commodity open-cut and underground operations. It partners with mining companies, contractors and original equipment manufacturers to create innovative engineering solutions that deliver productivity and safety improvements to their operations. It offers on and off-site repair and maintenance services. Austin’s products create more sustainable mining operations, delivering the lowest cost/tonne to the end-user, reducing fuel usage per load. It has operations in Australia, Asia, North and South America.

Speaker: Peter Forsyth, Managing Director

Booktopia Group (ASX: BKG) is the largest Australian-owned online book retailer by market share with revenue in FY2020 of $165.8 million. Over 85% of the items the Booktopia Group sold in FY2020 were books, however it also sells eBooks, DVDs, audiobooks, magazines, maps, calendars, puzzles, stationery and cards. The Sydney based business was launched in 2004. It sells its products through its websites and distributes product from its modern Distribution Centre located in Lidcombe, Sydney. 

Booktopia Group’s success in online book retailing has been driven by its capabilities in information technology, logistics, innovation, internet marketing, product knowledge and online retail. 

Speaker: Tony Nash, Founder and Chief Executive Officer

Dubber Corporation Limited (ASX:DUB) is unlocking the potential of voice data from any call or conversation. Dubber is the world’s most scalable Unified Call Recording service and Voice Intelligence Cloud adopted as core network infrastructure by multiple global leading telecommunications carriers in North America, Europe and Asia Pacific. Dubber allows service providers to offer call recording for compliance, business intelligence, sentiment analysis, AI and more on any phone. Dubber is a disruptive innovator in the multi-billion dollar call recording industry, its Software as a Service offering removes the need for on-premise hardware, applications, or costly and limited storage.

Speaker: Steve McGovern, Chief Executive Officer

Hazer Group Limited (ASX: HZR). The HAZER® Process enables the effective conversion of natural gas, and similar feedstocks, into hydrogen and high-quality graphite, using iron ore as a process catalyst. The aim of the HAZER® Process will be to achieve savings for the hydrogen producer, as well as providing ‘clean’ hydrogen with significantly lower carbon dioxide emissions, enabling such hydrogen to be used in a range of developing ‘clean energy’ applications, as well as in large existing chemical processing industries.

Speaker: Geoff Ward, Chief Executive Officer and Managing Director

Janison Education Group Limited (ASX: JAN) creates an online assessment and learning solutions for governments, educators and corporations that are scalable from hundreds to millions of test-takers and learners. Our assessment instruments are authentic, provide greater student insight, and more reliable data within a faster timeframe; and our technology platform supports a commitment to equity and accessibility for all. 

Speaker: David Caspari, Chief Executive Officer

Mader Group Limited (ASX: MAD) is a solution-driven global maintenance provider powered by mechanically minded specialists. We are passionate about heavy equipment maintenance and dedicated to helping our customers maximise productivity and achieve targets through optimal fleet and plant performance. Today we work across the globe, deploying over 1,400 highly skilled and dynamic employees throughout the major mining regions of Australia, Asia, Africa and the Americas. A feat only made possible through sourcing and retaining the best.

Speaker: Justin Nuich, Chief Executive Officer and Executive Director

MyDeal.com.au Limited (ASX: MYD) is an online retail marketplace focused on household goods such as furniture and homewares. MyDeal currently has more than 1,700 sellers (of which close to 900 are considered Active Sellers as at 31 December 2020) on its platform with over 5 million product SKUs listed across over 2,000 categories (with the number of SKUs available for sale at any time determined by the sellers).

Speaker: Sean Senvirtne, Chief Executive Officer 

Plexure Group Limited (ASX: PX1) founded in NZ in 2010 to redefine the customer shopping experience, Plexure (ASX: PX1) is now one of the world’s leading specialist, mobile engagement solution providers transforming customer experiences for some of the world’s best-known brands. Consumer Brands that use Plexure experience an increase in customer numbers and visit frequency, higher average transaction values, larger share of wallet and improved customer satisfaction scores. Harnessing the power of data and artificial intelligence (Ai) to create magical moments for people, we help incentivise desired behaviours throughout the customer journey. We do this using an intelligent technology platform that delivers personalisation along with powerful analytics that enable one-to-one digital targeting at the right time and place.

Speaker: Craig Herbison, Chief Executive Officer

AUCloud (ASX: SOV) provides highly secure, standards-based, sovereign cloud Infrastructure as a Services to the Australian Government and Critical National Industry communities. Managed, operated and monitored in Australia by security cleared Australian citizens, all AUCloud services and the data we host, always remains in Australia. This includes account data, metadata, support, administrative and derived analytics data. As an Australian owned company, we are only subject to Australian law. AUCloud solutions enable customers to benefit from sovereign data protection with the scale, automation, elasticity and lower costs typically associated with global cloud offerings. 

Speaker: Phil Dawson, Managing Director

Straker Translations Limited (ASX: STG) based in New Zealand, has established itself as a world-leading Ai data-driven translation platform powering the global growth of businesses. Straker Translations has developed a hybrid translation platform that utilises a combination of Ai, machine learning, and a crowd-sourced pool of freelance translators. The company’s cloud-based platform manages the end-to-end translation process, leveraging Ai and machine-learning to create a first draft translation and subsequently matching the customer’s content with one or more of the approximately 13,000 crowd-sourced human freelance translators for refinement. This process is managed using Straker’s proprietary “RAY Platform.

Speaker: Grant Straker, Chief Executive Officer

Zebit Inc (ASX: ZBT) is a California based eCommerce company that is dedicated to making a fundamental change in the lives of Financially Underserved Consumers by giving them access to a broad set of products and the ability to pay for those products in instalments over six months.  Zebit sells products as an eCommerce merchant and provides financing to customers via an in-house and proprietary BNPL solution.  Zebit has consistently demonstrated its ability to deliver strong growth and has built impressive customer loyalty since its inception.

Speaker: Marc Schneider, President and Chief Executive Officer 

Alcidon (ASX:ALC) offers a smart and innovative clinical decision support platform that utilises AI, data, automated workflows to detect emerging patient risks to doctors and nurses. Alcidion’s technology meets the growing demand in the global healthcare market for digital tools that aggregate, analyse and report health data in real-time, to improve collaboration across clinical teams, and enable better planning, coordination and delivery of patient care. With over 25 years’ experience dedicated to improving healthcare through the use of technology, Alcidion brings together the best technology and health domain knowledge to deliver solutions that make healthcare better for everyone.

Speaker: Kate Quirke, MD, CEO & Exec. Director

Aroa Biosurgery (ASX: ARX) is a soft-tissue regeneration company that develops, manufactures, sells and distributes medical and surgical products to improve healing in complex wounds and soft tissue reconstruction. Committed to ‘unlocking regenerative healing for everybody’, its products are developed from the Company’s proprietary Endoform® technology platform, a novel extracellular matrix biomaterial derived from ovine (sheep) forestomach. Clinically proven with peer-reviewed publications, Aroa’s products have been used in more than four million procedures to date, with distribution into its key market of the United States. 

Speaker: Brian Ward, CEO

Aussie Broadband (ASX: ABB) is an ASX Listed telecommunications company that was formed in 2008 and is based in Morwell Victoria, Australia. The Company’s main focus is nbn™ subscription plans and bundles to residential homes, small businesses, not-for-profits, corporates and managed service providers. As a licensed carrier, the Company provides these services through a wholesale agreement with NBN Co, a mix of leased backhaul infrastructure from third parties and its own network equipment. The Company also offers a range of other telecommunications services including VOIP, mobile plans, entertainment bundles through its partnership with Fetch TV and connections through the Opticomm network.

Speaker: Phillip Britt, MD

Established in 1966, Auswide Bank Limited (ASX: ABA) provides home loans, consumer and business lending through its national online offering, branch and broker networks. With a strong legacy in Regional Queensland and a growing presence in SE Qld, NSW and VIC, Auswide is also the jersey sponsor of the Qld Maroons.

Speaker: Martin Barrett, MD

Botanix Pharmaceuticals Limited (ASX: BOT) is a clinical-stage synthetic cannabinoid company committed to the development of pharmaceutical products that are underpinned by science and supported by well-controlled randomised clinical trials.  The Company is developing a pipeline of product candidates that leverages the antimicrobial properties of cannabinoids with the BTX 1801 Phase 2a study for the prevention of surgical site infections completed and awaiting data.  For the dermatology platform, the Company has confirmed a drug development plan for the BTX 1503 acne program to support registration and plans to initiate its Phase 1b rosacea study in 1H CY2021.

Speaker: Vince Ippolito, President & Exec. Chairman

Doctor Care Anywhere Group PLC (ASX: DOC) is a UK-based telehealth company that is committed to delivering the very best patient experience and clinical care through digitally enabled, joined-up, evidence-based pathways on its proprietary platform. DOC utilises its relationships with health insurers, healthcare providers and corporate customers to connect with patients to deliver a range of telehealth services.

Speaker: Bayju Thakar, CEO

EMVision Medical Devices Limited (ASX: EMV) aims to be a leader in transformative point-of-care imaging, solving clinical problems where there are currently no solutions.  The Company’s lead product in development is a portable brain scanner for the rapid diagnosis and monitoring of time-sensitive neurological disorders such as stroke and traumatic brain injury. The Company recently reported very encouraging data from its pilot clinical trial. Learnings from this trial across usability, algorithms, software and general mechanical design have led to incremental improvements in the Company’s 1st Gen commercial device in development.

Speaker: Dr Ron Weinberger, CEO

Harmoney (ASX: HMY) is a 100% online direct personal lender that operates across ANZ providing customers with unsecured personal loans that are easy to access and competitively priced. Harmoney’s purpose is to help people achieve their goals through financial products that are fair, friendly, and simple to use. Harmoney’s proprietary digital lending platform, Stellare™, facilitates its personalised loan product with applications processed and loans typically funded within 24 hours of acceptance by the customer. Stellare™ applies a customer’s individual circumstance to its data-driven, machine learning credit scorecard to deliver automated credit decisioning and accurate risk-based pricing.

Speaker: David Stevens, CEO & MD

hipages (ASX: HPG) in the online platform that connects Australia with trusted tradies to simplify home improvement. As the leader in the On-Demand Tradie Economy, based on jobs posted, our aim is to create a seamless experience for both tradies and homeowners. For homeowners, hipages provides a better, smarter way to connect with local tradies to get the job done well. For tradies, the platform helps them grow their business by providing quality leads from customers looking for a specific trade. To date, over three million Australians have changed the way they find, hire and manage trusted tradies with hipages, ultimately providing more work to the 36,000 tradies subscribed to the platform. 

Speaker: Melissa Fahey, CFO & COO

Laybuy Group Holdings (ASX: LBY) launched in 2017 it's New Zealand’s leading Buy Now, Pay Later (BNPL) service with a growing presence in the United Kingdom and Australia. Its unique, fully integrated payment platform is helping revolutionise the way we spend. Laybuy is simple and allows consumers to stagger their payments while also providing merchants with a low risk payment option. Laybuy customers can shop at any of Laybuy’s >5,000 partner merchants, either online or instore, and receive their purchase straight away. They then split their repayments across six weekly, interest-free instalments, the first being at the point of sale..

Speaker: Gary Rohloff, Co-Founder and Managing Director

Noxopharm Limited (ASX: NOX) is an Australian clinical-stage drug development company focused on large markets of unmet medical need including a broad range of solid tumour cancers. Veyonda® is the lead drug candidate, an immunotherapy drug, which has a major commercial opportunity with its ability to address arguably the major challenge in cancer therapy – namely, the need to reintroduce immune function to tumours, so-called converting tumours from COLD to HOT. www.noxopharm.com

Speaker: Dr Graham Kelly,  Managing Director and Chief Executive Officer

Plenti Group Limited (ASX: PLT) is a technology-led consumer lending and investment business. Plenti provides borrowers in the large lending verticals of automotive, renewable energy and personal lending with efficient, simple and competitive loans, delivered via Venus, the Company’s proprietary technology platform. Additionally, Plenti seeks to provide investors with attractive, stable returns via investing in the established asset class of consumer loans.

Speaker: Daniel Foggo, Chief Executive Officer

Anteris Technologies Limited (ASX:AVR) is a structural heart company focused on delivering clinically superior solutions that create life-changing outcomes for patients. Its ADAPT® tissue platform, a next-generation technology with zero DNA and zero glutaraldehyde is the only bioscaffold to demonstrate zero calcification after 10 years of use in complex cardiac surgery. With these advantages, Anteris’ best-in-class ADAPT® tissue combined with its valve design has the potential to solve the problems associated with current aortic valve replacement options which are durability and preventing valve degradation.

Speaker: Wayne Paterson, CEO

Ardiden Limited (ASX: ADV) is an ASX-listed exploration company focused on discovery and building a significant high-grade gold resource at its Pickle Lake Gold Project, located in north-west Ontario, one of Canada’s most prolific gold mining districts.

The District-scale Pickle Lake Gold Project consists of 870km2 of highly prospective and connected landholdings across 22 identified Gold Deposits and Prospects.

Ardiden also has 100% ownership of three hard rock (spodumene) Lithium Projects in northwest Ontario and is well-positioned to derive benefit from both gold and lithium exploration sectors of the market

Speaker: Rob Longley, MD & CEO

Armour Energy Limited (ASX: AJQ) is an ASX listed exploration and production company that is focussed on the discovery, development and production of world-class gas and associated liquids resources, delivering to the East Coast Domestic Gas Market.

The Armour Energy portfolio consists of exploration plays, reflecting a mix of moderate-risk and early exploration; with assets across northern, southern, and eastern Australia, with its flagship project based in Kincora, Queensland. 

Armour's exploration portfolio includes the Bowen-Surat Basin, Isa Superbasin, South Nicholson and Georgina Basins in Queensland and the McArthur Basin in the Northern Territory. Armour also has oil exploration in Uganda and exploration interests in the onshore Gippsland Basin in Victoria in joint venture with Lakes Oil and the Cooper Basin in South Australia, for gas and associated petroleum liquids. 

Speaker: Brad Lingo, CEO

Bailador Technology Investments Limited (ASX: BTI) is a growth capital fund focused on the information technology sector, actively managed by an experienced team with demonstrated sector expertise. Bailador provides exposure to a portfolio of information technology companies with global addressable markets. We invest in private technology companies at the expansion stage. Bailador favours the SaaS and Marketplace models for their ability to address global market opportunities, scale efficiently and generate a predictable recurring revenue stream. Bailador currently has a portfolio of nine companies and the majority of these are global businesses with on average >75% of revenue generated offshore. 

Speaker: Paul Wilson, Co-Founder & Managing Partner

Cynata Therapeutics Limited (ASX:CYP) is a clinical-stage stem cell and regenerative medicine company developing a therapeutic stem cell platform technology, Cymerus™. A successful world-first clinical trial in graft-versus-host disease has been completed, meeting all safety and efficacy endpoints and this product is now the subject of a global license with Fujifilm potentially yielding future revenues of over A$100m. A Phase 3 clinical trial in osteoarthritis and a Phase 2 clinical trial in COVID-19 commenced in 2020. Cynata recently raised $18.3m cornerstoned by BioScience Managers, a leading global healthcare institutional investor. The other major shareholder is Fidelity, one of the world’s largest investment houses

Speaker: Ross A Macdonald, CEO

dorsaVi Limited (ASX: DVL) is a revenue-generating medical device company commercialising its suite of innovative motion analysis technologies. DVL’s revolutionary wearable sensors, which accurately measures muscle activity and movement, has built strong traction in both workplace and clinical applications. This has attracted an impressive blue-chip customer base including Coles, BHP, Amazon, Heathrow Airport, Caterpillar and is currently used by >300 physical therapy sites in the US. DVL is executing on its commercialisation strategy, underpinned by a reliable recurring revenue-led business model and supported by recent contract wins and strong, technology-focused and data-driven tailwinds.

Speaker: Andrew Ronchi, CEO

IMEXHS Limited (ASX: IME) is a leading imaging Software-as-a-Service (SaaS) and ancillary solutions provider with over 270 customers across 15 countries. Founded in 2012, IMEXHS is known for its innovation in the imaging services market, offering flexible and scalable imaging solutions via its HIRUKO branded suite of solutions for next-generation Picture Archiving and Communications System (PACS) and integrated medical imaging systems.

Speaker: Dr. German Arango, CEO & Co-founder

IODM Limited (ASX: IOD) is a leading accounts receivable (AR) solution that utilises digital technology to optimise automation. IODM’s solution provides an end-to-end AR process that supports customers with invoicing, query management, payment reminders, escalation, analytics and more. IODM’s solution drives increased client productivity and timely payments while reducing costs and minimising human error. The solution is a customisable application that seamlessly integrates with any accounting ERP software package. IODM operates globally and is headquartered in Melbourne, Australia. To learn more, please visit www.iodmconnect.com

Speaker: Mark Reilly, CEO

Mayur Resources (ASX:MRL) is focused on the development of natural resources in Papua New Guinea. The maturation of Mayur’s diversified asset portfolio, which spans industrial minerals, power generation, coal, copper and gold has provided a platform to drive long term shareholder value while contributing to nation-building and job creation in a country experiencing a significant growth trajectory. The Company’s flagship Central Cement and Lime project is permitted and shovel ready with funding in place to support offtake deals, early quarry operation cash flow opportunities, and strategic partnerships. Mayur is now progressing a disaggregation strategy to unlock the full value of its portfolio of projects. This commenced with the spin-out of its key copper and gold assets into Adyton Resources, listed on the TSX Venture Exchange. 

Speaker: Paul Mulder, MD

Micro-X Limited (ASX:MX1) is an ASX listed hi-tech company developing and commercialising a range of innovative products for global health and security markets, based on proprietary cold cathode, carbon nanotube (CNT) emitter technology. The electronic control of emitters with this technology enables x-ray products with a significant reduction in size, weight and power requirements, enabling greater mobility and ease of use in existing x-ray markets and a range of new and unique security and defence applications. Micro-X has two mobile digital medical x-ray systems sold commercially for diagnostic healthcare applications and a portfolio of products in development. 

Speaker: Peter Rowland, MD

Osprey Medical Inc. (ASX:OSP) is a revenue-generating medical devices company, improving outcomes in patients with Chronic Kidney Disease by reducing the amount of contrast (dye) injected into patients during heart catherization procedures, through its DyeVert technology, the only FDA-cleared product for reducing dye dosage. Based in the US, its core focus has been penetrating the US market through both its direct and cost-effective, distributor salesforce. Osprey recently signed a milestone agreement with global giant, GE Healthcare, who will commercialise Osprey’s technologies in Europe, Russia, Middle East, Africa, Central Asia and Turkey; and with another distributor to enter Australia & New Zealand. 

Speaker: Mike McCormick, President & CEO

Star Combo Pharma Limited (ASX: S66) is a leading manufacturer and distributor of premium health and natural beauty products, with its high-quality development and manufacturing facilities located in Sydney.

Founded and directed by pharmacists and experts in health and supplement manufacturing, Star Combo’s curated health products are made from natural ingredients backed with scientific Research and Development and involve the highest standard manufacturing practices. Some of Australia’s leading supplement brands contract manufacturing to Star Combo Pharma while our own brand and product development team continues to produce products demanded by a growing market.

Speaker: Su Zhang, CEO

Swick Mining Services Ltd (ASX: SWK) is one of Australia’s largest mineral drilling contractors, providing high-quality underground diamond drilling services to a diverse group of mining companies. Swick was the pioneer of the first mobile underground diamond drill rig and since its inception in 2004, the Company has built over 70 mobile rigs and has proudly drilled over 12 million metres of underground core, the equivalent of having cored through the earth. Employing over 650 people, Swick has a global presence with operational revenue from Australia, United States, Portugal and Spain. In FY2020 the Drilling Business delivered revenue of $149.6 million and EBITDA of $24.6 million.

The Company has a history of innovation having established a Mineral Technology Business, Orexplore, which provides real-time mineral core analysis. 

Speaker: Kent Swick , MD

9Spokes International Limited (ASX:9SP) is a powerful business ecosystem with global scale. It offers modern businesses a management app that brings meaningful data together across a business, its apps, and its bank. 9Spokes delivers meaningful, personalized, and shareable insights to businesses to help inform their next move and steer them towards their goals. It’s a collaborative resource that facilitates holistic conversations between SMBs and their banks that go beyond just the financials, helping to improve visibility and reduce risk. Businesses gain a value-added business hub, while their banks get the insights needed to offer products and services better tailored to their customers’ needs.

Speaker: Adrian Grant, Co-founder and Chief Executive

Actinogen Medical Limited (ASX:ACW) is an ASX-listed biotechnology company developing novel therapies for cognitive impairment associated with significant neurological and metabolic diseases, including Alzheimer’s disease (AD). Actinogen Medical’s lead drug Xanamem has been specifically designed to reduce the production of excess cortisol in the brain via antagonism of neuronally expressed 11β-HSD1. Drugs that reduce cortisol in the brain offer a promising new approach to slowing, or even preventing, the cognitive decline associated with Alzheimer’s disease and a range of other neurological disorders.

Speaker: Dr. Bill Ketelbey, Chief Executive Officer and Managing Director

Botanix Pharmaceuticals Limited (ASX:BOT)  is a clinical-stage synthetic cannabinoid pharmaceutical company with a targeted pipeline of dermatology and antimicrobial products. We have attracted a world-class team and significant capital to support the progression of our products. We are moving quickly, but never at the expense of our rigorous commitment to ethical research and development (R&D) and the highest clinical standards mandated by the US Food and Drug Administration (FDA). Our goal is to unlock the true potential of synthetic cannabinoids for people around the world, with an evidence-first approach

Speaker: Vince Ippolito, President and Executive Chairman

DomaCom Limited (ASX:DCL) owns and operates a fractional investment platform that provides real solutions for SMSF’s, retirees and new home buyers. Using the DomaCom platform, investors can make fractional investments in a range of asset classes including property-related investments, mortgage-backed securities, renewables, affordable housing, disability accommodation and debt securities via a unique trust structure tailored to them. DomaCom runs a crowdfunding campaign process in which investors can commit as much as they want towards the purchase of assets together with other like-minded investors. When a campaign is complete, DomaCom purchases the asset places it in a sub-fund, and issues the investors with units in proportion to the amount they invested. DomaCom’s proprietary platform allows Australians to invest in almost any asset class, empowering them to create diversified portfolios with comparatively lower minimum investments and competitive cost structures. To learn more, please visit: www.domacom.com.au 

Speaker: Arthur Naoumidis, Chief Executive Officer

Genetic Signatures Limited (ASX:GSS) is a specialist molecular diagnostics company focused on the development and commercialisation of its proprietary platform technology, 3base™. Genetic Signatures designs and manufactures a suite of real-time Polymerase Chain Reaction (PCR) based products for the routine detection of infectious diseases under the EasyScreen™ brand, including a SARS-CoV-2 (the virus that causes COVID-19) test. Genetic Signatures’ proprietary MDx 3base™ platform technology provides high-volume hospital and pathology laboratories the ability to screen for a wide array of infectious pathogens, with a high degree of specificity, in a rapid throughput (time-to-result) environment.

Speaker: Dr. John Melki, Chief Executive Officer

Immutep Limited (ASX:IMM) is focused on improving the lives of patients by leveraging the body’s immune system. We are leaders in the development of products targeting the LAG-3 immune checkpoint, which was discovered by our CMO & CSO, Dr Triebel. Immutep continues to build a strong pool of data supporting the efficacy of our lead candidate, efti in multiple cancer indications. We have committed partnerships with five of the world’s largest pharmaceutical companies: MSD, Pfizer, Merck, Novartis, GSK. This provides validation of our product candidates for cancer and autoimmune diseases. We have a strong pipeline of news flow ahead from our own trials and from those of our partners in 2020 and beyond.

Speaker: Marc Voigt, Chief Executive Officer, Executive Director, Chief Financial Officer

Kazia Therapuetics Limited (ASX:KZA) is an Australian oncology company developing innovative, high-impact drugs for cancer. Their lead program is paxalisib, which is being developed to treat glioblastoma, the most common and most aggressive form of primary brain cancer in adults.

Speaker: James Garner, Chief Executive Officer, Executive Director

Sayona Mining Limited (ASX:SYA) is an emerging lithium miner, with projects in Québec, Canada and Western Australia. In Québec, Sayona is progressing a bid for the North American Lithium mine with the backing of a world-class advisory team, while advancing its flagship Authier Lithium Project and its nearby Tansim project. In Western Australia, the Company has an earn-in agreement with leading lithium producer Altura Mining concerning its lithium and gold exploration portfolio in the Pilbara. Amid the accelerating EV and battery revolution in North America, Europe and Asia, Sayona is backing Québec's lithium expansion as the most economical, strategic and environmental supplier of choice.

Speaker: Brett Lynch, Chief Executive Officer and Managing Director